hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 10.00
-0.25 (-2.44%)
Aug 1, 2025, 4:38 PM GMT+1
Chimerix Revenue
In the year 2024, hVIVO had annual revenue of 66.22M GBP with 12.87% growth. hVIVO had revenue of 29.02M in the half year ending December 31, 2024, a decrease of -8.80%.
Revenue
66.22M
Revenue Growth
+12.87%
P/S Ratio
1.03
Revenue / Employee
219.99K
Employees
301
Market Cap
68.04M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 66.22M | 7.55M | 12.87% |
| Dec 31, 2023 | 58.67M | 7.97M | 15.72% |
| Dec 31, 2022 | 50.70M | 11.69M | 29.98% |
| Dec 31, 2021 | 39.01M | 17.06M | 77.76% |
| Dec 31, 2020 | 21.94M | 18.57M | 550.71% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 31.63B |
| Haleon | 11.02B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.72B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
hVIVO News
- 4 months ago - Cathal Friel to step down as HVivo chairman - Independent Ireland
- 11 months ago - Half Year 2024 hVIVO PLC Investor Presentation Transcript - GuruFocus
- 11 months ago - Earnings rise 68pc at pharmaceutical services firm Hvivo - Independent Ireland